MetLife Investment Management’s Select Medical SEM Stock Holding History

MetLife Investment Management’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$996K	Hold	60,340	–	–	﹤0.01%	1525
2026 Q1	$983K	Sell	60,340 -656	-1%	-$10.3K	0.01%	1406
2025 Q4	$906K	Sell	60,996 -3,850	-6%	-$54.4K	﹤0.01%	1485
2025 Q3	$833K	Hold	64,846	–	–	﹤0.01%	1563
2025 Q2	$984K	Hold	64,846	–	–	0.01%	1321
2025 Q1	$1.08M	Sell	64,846 -966	-1%	-$17.8K	0.01%	1325
2024 Q4	$1.24M	Sell	65,812 -48,716	-43%	-$939K	0.01%	1307
2024 Q3	$2.15M	Hold	114,528	–	–	0.01%	979
2024 Q2	$2.16M	Buy	114,528 +15,373	+16%	+$262K	0.01%	935
2024 Q1	$1.61M	Sell	99,155 -2,825	-3%	-$41.4K	0.01%	1056
2023 Q4	$1.29M	Hold	101,980	–	–	0.01%	1169
2023 Q3	$1.39M	Hold	101,980	–	–	0.01%	1065
2023 Q2	$1.75M	Hold	101,980	–	–	0.01%	987
2023 Q1	$1.42M	Hold	101,980	–	–	0.01%	1047
2022 Q4	$1.36M	Hold	101,980	–	–	0.01%	1058
2022 Q3	$1.21M	Sell	101,980 -4,734	-4%	-$67.2K	0.01%	1093
2022 Q2	$1.36M	Sell	106,714 -3,796	-3%	-$48.7K	0.01%	1062
2022 Q1	$1.43M	Buy	110,510 +35,169	+47%	+$464K	0.01%	1137
2021 Q4	$1.19M	Hold	75,341	–	–	0.01%	1057
2021 Q3	$1.47M	Hold	75,341	–	–	0.01%	965
2021 Q2	$1.72M	Hold	75,341	–	–	0.02%	934
2021 Q1	$1.38M	Sell	75,341 -6,045	-7%	-$99.1K	0.01%	990
2020 Q4	$1.21M	Sell	81,386 -7,557	-8%	-$98.6K	0.01%	1042
2020 Q3	$998K	Hold	88,943	–	–	0.01%	1029
2020 Q2	$706K	Hold	88,943	–	–	0.01%	1191
2020 Q1	$719K	Hold	88,943	–	–	0.01%	1040
2019 Q4	$1.12M	Hold	88,943	–	–	0.01%	1044
2019 Q3	$794K	Sell	88,943 -10,333	-10%	-$90.3K	0.01%	1174
2019 Q2	$849K	Buy	99,276 +11,329	+13%	+$89.5K	0.01%	1188
2019 Q1	$668K	Hold	87,947	–	–	0.01%	1286
2018 Q4	$727K	Hold	87,947	–	–	0.01%	1156
2018 Q3	$872K	Sell	87,947 -10,349	-11%	-$107K	0.01%	1205
2018 Q2	$961K	Hold	98,296	–	–	0.01%	1032
2018 Q1	$914K	Hold	98,296	–	–	0.01%	1040
2017 Q4	$935K	Buy	+98,296	New	+$939K	0.01%	1054

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

MetLife Investment Management's SEM Position: Q2 2026 in Review

MetLife Investment Management held its Select Medical (SEM) position steady in Q2 2026 at 60,340 shares worth $996K. The position accounts for ﹤0.01% of the portfolio, ranked #1525.

MetLife Investment Management first reported a position in SEM in Q4 2017 and has held it in 35 quarters since. The position peaked at $2.16M in Q2 2024. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

MetLife Investment Management held 60,340 shares of Select Medical worth $996K as of Q2 2026.
MetLife Investment Management left its Select Medical share count unchanged in Q2 2026.
Select Medical made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1525 holding.
MetLife Investment Management first reported a position in Select Medical in Q4 2017 and has held it in 35 quarters since.
MetLife Investment Management's Select Medical position peaked at $2.16M in Q2 2024.
238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.